Virologic and Immunologic Outcomes after 24 Weeks in HIV Type 1–Infected Adolescents Receiving Highly Active Antiretroviral Therapy

Abstract

Adolescents have the capacity to improve their immunologic status with HAART. Lower than expected success in virologic control is related to lack of adherence, and efforts to improve treatment outcome must stress measures to assure adherence to medication.